Skip to main content

USANA HEALTH SCIENCES INC

For the period ended Jul 4, 2026. Filed Aug 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jul 4, 2026 · Filed Aug 13, 2026

USNA$13.85+1.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except par value)

As ofJuly 4,2026As ofJanuary 3, 2026
ASSETS
Current assets
Cash and cash equivalents$168,560$158,380
Trade accounts receivable (net of allowance of $92 and $137, respectively)3,3374,285
Inventories86,343102,608
Prepaid expenses and other current assets22,82623,132
Total current assets281,066288,405
Property and equipment, net94,26994,383
Goodwill109,141137,962
Intangible assets, net124,615133,151
Deferred tax assets29,53927,209
Other assets64,58061,805
Total assets$703,210$742,915
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST, AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable$15,431$17,263
Line of credit—14,000
Other current liabilities90,24497,302
Total current liabilities105,675128,565
Deferred tax liabilities4,6624,892
Other long-term liabilities21,90023,186
Total liabilities132,237156,643
Redeemable noncontrolling interest44,66753,168
Stockholders' equity
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 18,463 as of July 4, 2026 and 18,281 as of January 3, 20261818
Additional paid-in capital88,11183,544
Retained earnings451,853465,720
Accumulated other comprehensive income (loss)(13,676)(16,178)
Total stockholders' equity attributable to USANA526,306533,104
Total liabilities, redeemable noncontrolling interest, and stockholders' equity$703,210$742,915
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.